Skip to main content

Research on Chemical and Biological Defense

CFDA 12.360 · Federal Grants & Funding

Total Funding

$771.7M

Awards

16

Recipients

14

States

9

Last Updated

Feb 13, 2026

Yearly Funding Trend

Yearly federal funding for CFDA program 12.360 (Research on Chemical and Biological Defense), with obligated amounts, award counts, and year-over-year change.
Fiscal YearObligationsAwardsYoY Change
2024$730.4M14
2025$41.3M2-94.3%

Award Type Mix

CFDA program 12.360 (Research on Chemical and Biological Defense) federal awards broken down by award type, with obligated amounts and award counts.
TypeObligationsAwards
$00
$00

Top 16 Awards under CFDA 12.360

Largest individual obligations for Research on Chemical and Biological Defense.

Download CSV
Top 16 Awards under CFDA 12.360
AwardRecipientAwarding AgencyPlaceFYObligation
ASST_NON_W911NF2030004_097
COVID-19 ACTION: THE PURPOSE OF THIS MODIFICATION IS TO EXECUTE FINAL DE-OBLIGATION. NOTE, POP END DATE REFLECTS PRIORITY ACCESS PERIOD DUE TO SYSTEM REQUIRING ACTIVE POP TO EXECU…
CORNING INCORPORATED
New York
Department of Defense
Department of the Army
CORNING, NY-232024$231,401,977
ASST_NON_W911NF2030003_097
THE PURPOSE OF THIS MODIFICATION IS TO CORRECT THE PDF AND EDA INDEX TO REFLECT THE CORRECT ADMINISTRATION OFFICE AS DCMA OHIO RIVER VALLEY (DODAAC - S0140A)
SIO2 MEDICAL PRODUCTS INC
Alabama
Department of Defense
Defense Contract Management Agency
AUBURN, AL-032024$196,748,752
ASST_NON_W911NF2130001_097
COVID-19 ACTION: EXPANSION FOR COVID-19 RESPONSE FINAL DE-OBLIGATION.
GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
Massachusetts
Department of Defense
Department of the Army
MARLBOROUGH, MA-032024$108,070,263
ASST_NON_W58P052220001_097
COIVD-19 ACTION: FINAL DE-OBLIGATION CA TRANSFERRED TO HHS.
PAR STERILE PRODUCTS, LLC
Michigan
Department of Defense
Department of the Army
GRAND RAPIDS, MI-032024$57,093,544
ASST_NON_W58P052220013_097
COVID-19 ACTION: THE PURPOSE OF THIS MODIFICATION FINAL DEOBLIGATION OF FUNDS
CORNING INCORPORATED
New York
Department of Defense
Defense Contract Management Agency
CORNING, NY-232024$45,197,817
ASST_NON_W911SR2030001_097
DCMA GO 25-18 CHANGE PAY OFFICE FROM HQ0337 TO HQ0338
BECTON, DICKINSON AND CO
New Jersey
Department of Defense
Defense Contract Management Agency
NJ-902025$36,273,957
ASST_NON_W58P052220005_097
COVID-19 ACTION
OMPI OF AMERICA INC
Pennsylvania
Department of Defense
Defense Contract Management Agency
NEWTOWN, PA-012024$33,211,016
ASST_NON_W911QY2020005_097
MODIFICATION TO AD DFARS CLAUSE
UNIVERSITY OF MASSACHUSETTS LOWELL
Massachusetts
Department of Defense
Department of the Army
MA-902024$22,929,616
ASST_NON_W58P052220008_097
COVID-19 ACTION: PURPOSE OF THIS MODIFICATION IS AN ADMINISTRATIVE CHANGE FOR GFEBS AND MOCAS.
GERRESHEIMER GLASS INC
New Jersey
Department of Defense
Department of the Army
VINELAND, NJ-022024$18,297,471
ASST_NON_W911W62220001_097
DCMA CAO NAME CHANGE
SIKORSKY AIRCRAFT CORPORATION
Connecticut
Department of Defense
Defense Contract Management Agency
STRATFORD, CT-032024$6,412,412
ASST_NON_W911QY1510019_097
REMOVE UNLIQUIDATED OBLIGATIONS IN THE AMOUNT OF $104.35 FROM A COMPLETED RESEARCH AND DEVELOPMENT PROJECT.
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Pennsylvania
Department of Defense
Department of the Army
PITTSBURGH, PA-122024$5,500,389
ASST_NON_W911SR2530001_097
THIS OTHER TRANSACTION AGREEMENT (OTA) FOR RESEARCH IS FOR THE PERFORMANCE OF A PHASE II HUMAN CLINICAL TRIAL TO COLLECT EXPANDED SAFETY AND EFFICACY DATA FOR INNA-051.
ENA RESPIRATORY PTY LTDDepartment of Defense
Department of the Army
2025$5,000,000
ASST_NON_W911QY1510014_097
THE PURPOSE OF THIS AMENDMENT IS TO DEOBLIGATE FUNDING UNDER CLIN 000104, ACRN AD IN THE AMOUNT OF $178.35.
PROFECTUS BIOSCIENCES, INC.
Maryland
Department of Defense
Department of the Army
BALTIMORE, MD-072024$3,570,155
ASST_NON_HQ00342110002_097
FOUNDATIONS OF SOCIAL INFORMATION DYNAMICS AND CONTROL PROJECT.
UNIVERSITY OF ILLINOIS
Illinois
Department of Defense
Washington Headquarters Services
2024$1,500,000
ASST_NON_W911QY2120001_097
AMENDMENT TO EXTEND THE POP
NORTH CAROLINA STATE UNIVERSITY
North Carolina
Department of Defense
Department of the Army
WV-022024$450,000
ASST_NON_W58P052220014_097
COVID-19 ACTION: FINAL DE-OBLIGATION IN PREPARATION OF CLOSE OUT.
SIO2 MEDICAL PRODUCTS INC
Alabama
Department of Defense
Department of the Army
AUBURN, AL-032024$0

Top 16 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.

Spending by State

CFDA program 12.360 (Research on Chemical and Biological Defense) federal funding broken down by state, sorted by total obligated amount.
StateFundingAwards
New York$276.6M2
Alabama$196.7M2
Massachusetts$131.0M2
Michigan$57.1M1
New Jersey$54.6M2
Pennsylvania$38.7M2
Connecticut$6.4M1
Maryland$3.6M1
West Virginia$450K1

Top Recipients

Top recipients of CFDA program 12.360 (Research on Chemical and Biological Defense) federal funding, with total obligated amounts and award counts.
RecipientTotalAwards
CORNING INCORPORATEDNY$276.6M2
SIO2 MEDICAL PRODUCTS INCAL$196.7M2
GLOBAL LIFE SCIENCES SOLUTIONS USA LLCMA$108.1M1
PAR STERILE PRODUCTS, LLCMI$57.1M1
BECTON, DICKINSON AND CONJ$36.3M1
OMPI OF AMERICA INCPA$33.2M1
UNIVERSITY OF MASSACHUSETTS LOWELLMA$22.9M1
GERRESHEIMER GLASS INCNJ$18.3M1
SIKORSKY AIRCRAFT CORPORATIONCT$6.4M1
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATIONPA$5.5M1
ENA RESPIRATORY PTY LTD$5.0M1
PROFECTUS BIOSCIENCES, INC.MD$3.6M1
UNIVERSITY OF ILLINOISIL$1.5M1
NORTH CAROLINA STATE UNIVERSITYNC$450K1

Agencies Administering This Program